Simplex Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13K Buy
+633
New +$10.7K ﹤0.01% 7472
2025
Q3
– Sell
-10,821
Closed -$223K – 9355
2025
Q2
$215K Buy
10,821
+8,855
+450% +$173K ﹤0.01% 4429
2025
Q1
$33K Buy
+1,966
New +$33.5K ﹤0.01% 6161
2024
Q3
– Sell
-1,800
Closed -$40.2K – 8824
2024
Q2
$35K Sell
1,800
-2,446
-58% -$51.1K ﹤0.01% 6407
2024
Q1
$92K Buy
4,246
+1,779
+72% +$44.2K ﹤0.01% 5672
2023
Q4
$71K Buy
+2,467
New +$66K ﹤0.01% 5729
2023
Q3
– Sell
-10,996
Closed -$375K – 9000
2023
Q2
$407K Buy
10,996
+8,531
+346% +$297K ﹤0.01% 3524
2023
Q1
$76K Buy
+2,465
New +$79.3K ﹤0.01% 5466
2022
Q4
– Sell
-5,336
Closed -$191K – 9543
2022
Q3
$203K Buy
+5,336
New +$268K ﹤0.01% 4584
2022
Q1
– Sell
-1,865
Closed -$123K – 10700
2021
Q4
$187K Buy
1,865
+290
+18% +$25.5K ﹤0.01% 5297
2021
Q3
$137K Sell
1,575
-200
-11% -$18.2K ﹤0.01% 6164
2021
Q2
$163K Buy
+1,775
New +$142K ﹤0.01% 6017
2021
Q1
– Sell
-20,949
Closed -$2.16M – 9168
2020
Q4
$1.09M Buy
20,949
+20,198
+2,689% +$844K ﹤0.01% 2441
2020
Q3
$30K Buy
+751
New +$23.5K ﹤0.01% 6063

Other funds holding FLGT

Simplex Trading's FLGT Position: Q2 2026 in Review

Simplex Trading opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 633 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #7472 among its holdings. This is a return to the name: Simplex Trading previously reported a position in FLGT as recently as Q2 2025.

Simplex Trading first reported a position in FLGT in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.09M in Q4 2020. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Simplex Trading held 633 shares of Fulgent Genetics worth $13K as of Q2 2026.
  • Fulgent Genetics was a new Simplex Trading position in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7472 holding.
  • Simplex Trading first reported a position in Fulgent Genetics in Q3 2020 and has held it in 14 quarters since.
  • Simplex Trading's Fulgent Genetics position peaked at $1.09M in Q4 2020.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.